Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Enterprise Value : 230.04M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 230.04M |
| October 08, 2026 | 175.33M |
| October 07, 2026 | 193.15M |
| October 06, 2026 | 168.97M |
| October 05, 2026 | 181.70M |
| October 02, 2026 | 193.15M |
| October 01, 2026 | 143.53M |
| September 30, 2026 | 124.44M |
| September 29, 2026 | 117.45M |
| September 28, 2026 | 85.00M |
| September 25, 2026 | 66.26M |
| September 24, 2026 | 69.80M |
| September 23, 2026 | 65.14M |
| September 22, 2026 | 70.93M |
| September 21, 2026 | 65.25M |
| September 18, 2026 | 66.68M |
| September 17, 2026 | 67.41M |
| September 16, 2026 | 67.46M |
| September 15, 2026 | 57.15M |
| September 14, 2026 | 59.09M |
| September 11, 2026 | 73.55M |
| September 10, 2026 | 69.69M |
| September 09, 2026 | 86.28M |
| September 08, 2026 | 61.84M |
| September 04, 2026 | 58.91M |
| Date | Value |
|---|---|
| September 03, 2026 | 60.77M |
| September 02, 2026 | 66.15M |
| September 01, 2026 | 61.66M |
| August 31, 2026 | 67.50M |
| August 28, 2026 | 56.47M |
| August 27, 2026 | 58.81M |
| August 26, 2026 | 63.05M |
| August 25, 2026 | 55.91M |
| August 24, 2026 | 55.14M |
| August 21, 2026 | 65.22M |
| August 20, 2026 | 58.58M |
| August 19, 2026 | 58.48M |
| August 18, 2026 | 52.15M |
| August 17, 2026 | 55.81M |
| August 14, 2026 | 57.27M |
| August 13, 2026 | 57.01M |
| August 12, 2026 | 58.25M |
| August 11, 2026 | 57.12M |
| August 10, 2026 | 53.83M |
| August 07, 2026 | 58.30M |
| August 06, 2026 | 56.52M |
| August 05, 2026 | 62.10M |
| August 04, 2026 | 69.14M |
| August 03, 2026 | 72.28M |
| July 31, 2026 | 68.08M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 50.28B |
| Bio-Rad Laboratories, Inc. | 9.541B |
| Bruker Corp. | 10.62B |
| Danaher Corp. | 178.03B |
| Harvard Bioscience, Inc. | 75.21M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.47M |
| Revenue (Quarterly) | 0.19M |
| Total Expenses (Quarterly) | 14.66M |
| EPS Diluted (Quarterly) | -0.1138 |
| Gross Profit Margin (Quarterly) | -583.7% |
| Profit Margin (Quarterly) | -7.62K% |
| Earnings Yield | -19.84% |
| Normalized Earnings Yield | -19.84 |